Women are now leaving the workforce at four times the rate of men. What needs to be done to alleviate this?
Companies need to show that they are committed to the upward mobility of women in the workplace through their actions. This includes both providing challenging roles for women and allowing for flexible work schedules. At Lyra, we’re proud that we have attracted and retained women at all levels, and more than half of our company leaders are women.
Who was your mentor and what are you now doing to send the elevator back down?
What’s most important to me about mentorship is empowering women executives in leadership roles in science and biotechnology, fields in which women are underrepresented in executive roles. I appreciate those who mentored me in my career, and I’m paying that forward by being a mentor for up-and-coming women executives in biotech and serving on the board of MedExecWomen.
What is your golden rule at work?
It’s important to think big and have a relentlessly positive attitude. I encourage everyone to be persistent and committed to the goals they set for themselves, their team and the organization.
How have you coped with the unique challenges of the past 12 months?
My biggest challenge in the last year was guiding my company through one of the first IPOs after lockdown for the COVID-19 pandemic. We were one of the first three biotech companies to conduct a virtual IPO road show — an entirely new phenomenon from traditional in-person investor meetings — which ultimately led to a successful IPO. During this challenging time, I credit my team for maintaining their conviction to Lyra’s goals and value proposition for patients and very effectively transitioning to a virtual work environment.
What are the first things you plan to do when the pandemic ends?
I am really looking forward to being surrounded by and interacting with all of the people who are important to me — people at work, people I know and respect in the biotech industry and, of course, my extended family.